Patents by Inventor Caroline Loewy

Caroline Loewy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220249516
    Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
    Type: Application
    Filed: April 20, 2022
    Publication date: August 11, 2022
    Applicant: Corcept Therapeutic Inc.
    Inventors: Joe Belanoff, Robert Roe, Caroline Loewy
  • Publication number: 20210046093
    Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
    Type: Application
    Filed: November 3, 2020
    Publication date: February 18, 2021
    Inventors: Joe Belanoff, Robert Roe, Caroline Loewy
  • Patent number: 10842801
    Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: November 24, 2020
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Joe Belanoff, Robert Roe, Caroline Loewy
  • Publication number: 20200009159
    Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
    Type: Application
    Filed: September 18, 2019
    Publication date: January 9, 2020
    Inventors: Joe Belanoff, Robert Roe, Caroline Loewy
  • Patent number: 10500216
    Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: December 10, 2019
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Joe Belanoff, Robert Roe, Caroline Loewy